Company profile: Avitide
1.1 - Company Overview
Company description
- Provider of customized affinity purification solutions for biopharmaceuticals, including AVIPure affinity resins for custom and platform use, proprietary solutions to improve bioprocessing and manufacturing, a flexible, scalable commercial resin supply supported by ISO 9001:2015 operations, regulatory support and documentation, and AVIPure-AAV8 for single-step AAV8 purification with high yield, purity, and capacity.
Products and services
- Proprietary affinity purification systems: Custom-engineered, high-resolution affinity products that reduce process development timelines, program risks, and cost of production, enhancing bioprocess economics and manufacturing of biotherapeutics
- AVIPure affinity resins: Platform-ready affinity resins engineered for purification of biopharmaceuticals, suitable for both custom programs and platform applications across development and manufacturing
- AVIPure - AAV8: Virus-specific affinity chromatography resin enabling single-step purification of AAV8 from cell lysates with high yield, purity, and capacity
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Avitide
Hamilton Thorne
HQ: United States
Website
- Description: Provider of advanced laser systems and instruments for in-vitro cell applications in regenerative medicine research and fertility clinic markets. Offerings include ZILOS-tk and XYClone lasers that attach to inverted microscopes and act as robotic micro-surgeons; sperm analyzers and CASA platforms (IVOS II, TOX IVOS II), IVF equipment, and ZANDAIR PCOC3 in-duct air purification.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hamilton Thorne company profile →
DCN Diagnostics
HQ: United States
Website
- Description: Provider of lateral flow diagnostics development and manufacturing services, offering contract assay development across lateral flow, flow-through, dry chemistry, and microfluidic formats; design and integration of custom point-of-use readers and lab-on-a-chip systems; scalable manufacturing from clinical trials to commercialization; user-friendly sample collection devices and cartridges; and visual/fluorescent labeling and reporting solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DCN Diagnostics company profile →
Comecer
HQ: Italy
Website
- Description: Provider of protection technologies in nuclear medicine, isolation, and nuclear power plant equipment, and of screening systems for special applications serving hospitals, universities, industrial groups, and research organizations. Products include aseptic processing and containment systems, a Terbium-161 production line, the IRIS radiopharmaceutical injection system, THERABED protected admission management, ISP radioactive waste management, and dose calibrators.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Comecer company profile →
Ossiform
HQ: Denmark
Website
- Description: Provider of 3D bone printing solutions, including P3D Bone - bio-integrative, resorbable implants made from beta-tricalcium phosphate tailored to biomechanical needs; P3D Scaffolds - 3D printed bioceramic structures for cell culture, disease modeling, and drug screening; and Bone Printing Technology using beta-tricalcium phosphate to create implants with customizable porosity and mechanical properties.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ossiform company profile →
Lino Biotech
HQ: Switzerland
Website
- Description: Provider of focal molography—an entirely new, broadly patented, label-free method for measuring molecular interactions in living cells or crude biological samples—eliminating signal disturbances due to temperature changes or non-specific binding.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lino Biotech company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Avitide
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Avitide
2.2 - Growth funds investing in similar companies to Avitide
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Avitide
4.2 - Public trading comparable groups for Avitide
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →